From green propellants to cutting-edge microneedle technology, Kindeva is set to drive progress in drug delivery in 2025 and beyond. Our commitment to innovation and strategic growth is stronger than ever as we look to the next couple of years and further into the future.
Let’s fast-track healthier tomorrows together.
Leading the way in sustainable solutions
The pharmaceutical industry increasingly prioritises sustainability to address regulatory requirements and consumer demand for environmentally friendly products.
At Kindeva, we support these efforts by helping developers adopt low global warming potential (GWP) propellants, HFA152a and HFO1234ze.
Our commitment to environmental responsibility and comprehensive services will streamline the transition to sustainable drug delivery in 2025 and in the years to come. With clinical and commercial capabilities and our depth of expertise, we can meet your needs at any stage, from formulation through development to commercialisation and beyond.
Together, we can create a greener future for the pharmaceutical industry.
Embrace injectable drug delivery opportunities
The injectable drug market is booming, driven by the demand for GLP-1 receptor agonists and evolving regulations. We are at the front of this revolution, offering advanced filling solutions, a range of customised delivery systems and Annex 1 injectables compliance at our Bridgeton site, all in one location.
Our specialist expertise for 2025 and beyond includes:
- Advanced isolator technologies and flexible filling lines to meet the growing demand for sterile injectables.
- A range of customised drug delivery options, including prefilled syringes, autoinjectors, cartridges, wearable injectors and microneedle array patches.
Partner with us to navigate the complexities of the injectable drug market and deliver innovative solutions to patients worldwide now and in the future.
Your strategic CDMO partner
The role of CDMOs is transforming. They are no longer just service providers but strategic partners offering specialised expertise and advanced technologies to navigate the complexities of drug development.
Kindeva is your ideal strategically minded partner for 2025 and further into the future, with:
- Specialised expertise: Complex formulations and advanced drug delivery technologies, with specialist injectable, inhalation and dermal expertise.
- Streamlined operations: Technologically advanced, exceptional-by-design capabilities for greater efficiency.
- Integrated services: Finished-dose CDMO solutions with vertical and horizontal integration to handle all stages.
Let Kindeva help you turn long-term possibilities into achievable milestones.
If you missed us at DCAT Week 2025, connect with us now so we can help transform your aspirations into reality.
We meet the demands of today with the possibilities of tomorrow.